Home / You searched for Randomised Controlled Trials
A WORLD-LEADING cannabis professor says the UK is caught in a depressing Catch-22 with companies unwilling to invest in clinical...
Welcome to Business of Cannabis’ new research digest, unpacking the latest clinical evidence shaping cannabis therapeutics. While headlines often focus...
Ananda Pharma, one of the UK’s leading clinical-stage pharmaceutical cannabis companies, has announced a string of strategic pivots, including stepping...
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential,...
Why Reading Research Matters The volume of cannabis research has never been higher, but not all studies are created equal....
First published on Cannabis Health Medical cannabis patients made history in London with a first-of-its-kind, patient-led education event focused on...
Sorting Evidence from Anecdote As global cannabis research accelerates, the number of published studies has never been higher, but not...
Cannabis is now one of the most frequently discussed therapeutic agents in modern medicine, driven by expanding access programmes and...
Curaleaf Laboratories has been confirmed as headline sponsor of the inaugural Cannabis Health Symposium, taking place on 25 November 2025...
Written for Business of Cannabis by Releaf. The UK moved to legalise medical cannabis in 2018, but while the market...
Ananda Developments [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”ANA.AQ” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Aquis Stock Exchange-listed UK cannabis...
SCOTLAND-based medical cannabis cultivation and extraction business Hilltop Leaf has announced a new supply deal with Australian medical cannabis firm...